title: Ocular-motor profile and effects of memantine in a familial form of adult cerebellar ataxia with slow saccades and square wave saccadic intrusions.
abstract: Fixation instability due to saccadic intrusions is a feature of autosomal recessive spinocerebellar ataxias, and includes square wave intrusions (SWI) and macrosaccadic oscillations (MSO). A recent report suggested that the non-competitive antagonist of NMDA receptors, memantine, could decrease MSO and improve fixation in patients with spinocerebellar ataxia with saccadic intrusions (SCASI). We similarly tested two sisters, respectively of 58 and 60 years, with an unrecognized form of recessive, adult-onset cerebellar ataxia, peripheral neuropathy and slow saccades, who showed prominent SWI and also complained with difficulty in reading. We tested horizontal visually guided saccades (10°-18°) and three minutes of steady fixation in each patient and in thirty healthy controls. Both patients showed a significant reduction of peak and mean velocity compared with control subjects. Large SWI interrupting steady fixation were prominent during steady fixation and especially following visually guided saccades. Eye movements were recorded before and during the treatment with memantine, 20 mg/daily for 6 months. The treatment with memantine reduced both the magnitude and frequency of SWI (the former significantly), but did not modified neurological conditions or saccade parameters. Thus, our report suggests that memantine may have some general suppressive effect on saccadic intrusions, including both SWI and MSO, thereby restoring the capacity of reading and visual attention in these and in other recessive forms of ataxia, including Friedreich's, in which saccadic intrusions are prominent.
authors.affiliation: Eye tracking and Visual Application Lab (EVA Lab), Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Rosini
authors.forename: Pamela
authors.initials: P
authors.lastname: Federighi
authors.forename: Elena
authors.initials: E
authors.lastname: Pretegiani
authors.forename: Pietro
authors.initials: P
authors.lastname: Piu
authors.forename: R John
authors.initials: RJ
authors.lastname: Leigh
authors.forename: Alessandro
authors.initials: A
authors.lastname: Serra
authors.forename: Antonio
authors.initials: A
authors.lastname: Federico
authors.forename: Alessandra
authors.initials: A
authors.lastname: Rufa
mesh_terms: D000328:Adult; D001369:Axons / Q000187:drug effects / Q000473:pathology; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008559:Memantine / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology*; D012438:Saccades / Q000187:drug effects*
chemical_list: D008559:Memantine
references.citation: Brain. 2011 Mar;134(Pt 3):879-91
references.pmid: 21354979
references.citation: Brain. 1976 Sep;99(3):509-22
references.pmid: 1000284
references.citation: PLoS One. 2013;8(3):e58535
references.pmid: 23516502
references.citation: Ann Neurol. 2003 Dec;54(6):824-8
references.pmid: 14681893
references.citation: Brain Res. 2007 Apr 13;1141:154-67
references.pmid: 17313940
references.citation: J Neurosci. 2011 Mar 23;31(12):4379-87
references.pmid: 21430139
references.citation: Front Neurol. 2010 Dec 03;1:147
references.pmid: 21188269
references.citation: Neuroophthalmology. 1996 Apr;16(2):99-106
references.pmid: 11539873
references.citation: Neurology. 2008 Mar 4;70(10):810-2
references.pmid: 18316692
references.citation: Vision Res. 2002 Oct;42(22):2533-45
references.pmid: 12445847
references.citation: Curr Opin Pharmacol. 2006 Feb;6(1):61-7
references.pmid: 16368266
references.citation: Vision Res. 2004 Oct;44(23):2675-90
references.pmid: 15358063
references.citation: Ann N Y Acad Sci. 2011 Sep;1233:107-16
references.pmid: 21950983
references.citation: Neurology. 1977 Mar;27(3):278-81
references.pmid: 557766
references.citation: Brain. 2008 Apr;131(Pt 4):1035-45
references.pmid: 18238798
references.citation: J Neurol Sci. 1997 Feb 12;145(2):205-11
references.pmid: 9094050
references.citation: Mov Disord. 2009 Jul 15;24(9):1312-8
references.pmid: 19412943